Phialogics
Allschwil
About Phialogics
Phialogics is a preclinical biotech business with a focus on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Grant (Oct 2023)
- Website: phialogics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/phialogics-18931 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.